At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Market Closed 05-10 16:00:00 EDT
951.59
+14.06
+1.50%
High954.65Low937.27Vol47.78M
Open937.57D1 Closing937.53Amplitude1.85%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O818.69MT/O Rate--Tradable Shares0.00
P/B2.438548ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
E-Home Plans Shareholder Vote on Stock Consolidation
TIPRANKS  ·  05-11 06:28
E-Home Plans Shareholder Vote on Stock Consolidation
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
ACCESSWIRE  ·  05-11 04:05
Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
seekingalpha  ·  05-11 00:35
Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
Is Siga Technologies (SIGA) Stock Undervalued Right Now?
Zacks  ·  05-10 21:40
Is Siga Technologies (SIGA) Stock Undervalued Right Now?
BRIEF-Applied Dna Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
Reuters  ·  05-10 21:28
BRIEF-Applied Dna Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
Aethlon jumps on positive results from in vitro binding study of Hemopurifier device
seekingalpha  ·  05-10 21:13
Aethlon jumps on positive results from in vitro binding study of Hemopurifier device
RNAZ, QBTS and WAVD are among premarket gainers
seekingalpha  ·  05-10 21:02
RNAZ, QBTS and WAVD are among premarket gainers
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
ACCESSWIRE  ·  05-10 21:00
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Aethlon Medical Shares Double After Positive Results from Early Trial of Hemopurifier
Dow Jones  ·  05-10 20:14
Aethlon Medical Shares Double After Positive Results from Early Trial of Hemopurifier
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
PR Newswire  ·  05-10 20:01
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire  ·  05-10 12:00
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
GlobeNewswire  ·  05-10 11:17
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
seekingalpha  ·  05-10 05:13
Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Business Wire  ·  05-10 04:05
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
ACCESSWIRE  ·  05-09 21:45
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
MORNING BID AMERICAS-China trade heats up, UK rates in view
Reuters  ·  05-09
MORNING BID AMERICAS-China trade heats up, UK rates in view
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
GuruFocus.com  ·  05-09
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
What to Watch in the Day Ahead - Thursday, May 9
Reuters  ·  05-09
What to Watch in the Day Ahead - Thursday, May 9

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--